Imagine your child is dying. There’s a drug that promises hope, promises to stop your baby’s illness dead in its tracks. But this dream medicine is out of reach because it costs around $ 2 million, depending where you live. This is the story of many of parents of children with Spinal Muscular Atrophy (SMA), a rare motor neuron disease. Between one in 6,000… Read More »
AstraZeneca’s diabetes med Farxiga stormed the heart failure market with a first-in-class approval last year—and in chronic kidney disease, it just left would-be rival Jardiance in the dust. The FDA late Friday approved Farxiga, also known as dapagliflozin, to treat chronic kidney disease even in patients without diabetes. With that CKD approval in hand, Farxiga… Read More »
Traumatic brain injuries (TBI) often lead to cognitive disabilities and permanent neural tissue damage, for which effective therapies do not exist. The serious cognitive impairments that patients experience and the burden on caretakers can be enormous, necessitating a constant search for treatments that may help. Researchers at University of Georgia have now reported in journal… Read More »
The transport ban has left at least 50 percent of the workers unemployed, while the government kept shops and malls open in the pandemic lockdown, according to Bangladesh Road Transport Workers Federation. They urged the government to allow the public transports to run with half of their seats vacant, a requirement under the health protocols.… Read More »